List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 231 studies with search of: Latvia
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed A New Oral Treatment For Type II Diabetes Mellitus
Condition: Non-Insulin-Dependent Diabetes Mellitus
Intervention: Drug: GW0823093
2 Active, not recruiting "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
Condition: Prostate Cancer
Intervention: Drug: Dutasteride
3 Completed Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension
Condition: Hypertension
Intervention: Drug: Daglutril
4 Recruiting RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure;   Anemia;   Cardiovascular Disease;   Ventricular Dysfunction;   Congestive Heart Failure
Interventions: Drug: Darbepoetin alfa;   Drug: Placebo
5 Completed Study In Adults And Adolescents With Seasonal Allergic Rhinitis
Condition: Hayfever Allergic Rhinitis Seasonal Rhinitis
Intervention: Drug: GW685698X
6 Completed Switch Study of Existing Atypical Antipsychotics to Bifeprunox
Condition: Schizophrenia and Schizoaffective Disorder
Interventions: Drug: Aripiprazole;   Drug: Olanzapine;   Drug: Risperidone;   Drug: Quetiapine;   Drug: Ziprasidone;   Drug: Aripiprazole;   Drug: Olanzapine;   Drug: Risperidone;   Drug: Quetiapine;   Drug: Ziprasidone
7 Completed Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem
Condition: Infection
Interventions: Drug: Avelox (Moxifloxacin, BAY12-8039);   Drug: Ertapenem intravenous
8 Completed Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection
Conditions: Abscess;   Wound Infection;   Diabetic Foot;   Ulcer;   Infection
Interventions: Drug: Moxifloxacin intravenous and per os;   Drug: Piperacillin/Tazobactam intravenous, Amoxicillin/Clavulanic acid per os
9 Recruiting BI 10773 Phase II in T2D Patients, Open Label Extension
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: BI 10773;   Drug: Metformin;   Drug: Sitagliptin
10 Recruiting A Study of the Safety and Effectiveness of CNTO 148 (Golimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (CR014179)
Condition: Ulcerative Colitis
Interventions: Biological: Placebo;   Biological: Golimumab, placebo;   Biological: golimumab, placebo
11 Completed Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: GSK189075
12 Terminated GALLANT 22 Tesaglitazar vs. Placebo
Condition: Type 2 Diabetes
Interventions: Drug: Tesaglitazar;   Behavioral: Dietary and Lifestyle counseling
13 Terminated G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)
Condition: Type 2 Diabetes
Intervention:
14 Recruiting Study Evaluating the Safety and Efficacy of a Once-Daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections
Conditions: Bacterial Infections;   Diabetic Foot;   Osteomyelitis
Interventions: Drug: Tigecycline;   Drug: Ertapenem
15 Recruiting Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients
Condition: Venous Thromboembolism
Interventions: Drug: Rivaroxaban (BAY59-7939);   Drug: Enoxaparin
16 Enrolling by invitation Observation of Change in Clinical Global Impression Scores in Schizophrenia Patients Receiving Seroquel XR Treatment
Condition: Schizophrenia
Intervention:
17 Completed Rosiglitazone on Microalbuminuria in Type 2 Diabetics
Conditions: Type 2 Diabetes Mellitus;   Microalbuminuria
Intervention: Drug: Rosiglitazone
18 Completed Efficacy Study With 500 mg QD of TRO19622 vs Placebo in Patients With Painful Peripheral Diabetic Neuropathy
Condition: Diabetic Neuropathy
Interventions: Drug: Experimental;   Drug: Placebo comparator
19 Recruiting An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome.
Conditions: Acute Coronary Syndrome;   Myocardial Infarction;   Myocardial Ischemia;   Unstable Angina
Intervention: Drug: Rivaroxaban; Placebo
20 Active, not recruiting RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes
Condition: Type II Diabetes
Interventions: Drug: rosiglitazone;   Drug: metformin;   Drug: sulfonylurea

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services